Low-dose difluoromethylornithine and polyamine levels in human prostate tissue.
Messing
E M
EM
Department of Urology, University of Rochester Medical Center, NY, USA.
Love
R R
RR
Tutsch
K D
KD
Verma
A K
AK
Douglas
J
J
Pomplun
M
M
Simsiman
R
R
Wilding
G
G
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000518:Eflornithine / Q000008:administration & dosage / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008297:Male; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines / Q000032:analysis*; D011467:Prostate / Q000737:chemistry* / Q000187:drug effects* / Q000201:enzymology / Q000601:surgery; D011471:Prostatic Neoplasms / Q000737:chemistry* / Q000201:enzymology / Q000601:surgery; D011700:Putrescine / Q000032:analysis; D001749:Urinary Bladder Neoplasms / Q000737:chemistry* / Q000201:enzymology / Q000601:surgery
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D065108:Ornithine Decarboxylase Inhibitors; D011073:Polyamines; D011700:Putrescine; D000518:Eflornithine